Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

In Vivo Cross-Modal Imaging of Skin

NCT07188948 · tracked via the Priya Life Science USA tracker
Sponsor
Gabriel Sanchez
Phase
Observational
Started
2025-09-02
Last updated
2025-09-23

Condition(s) studied

Skin

Investigational drug(s) / intervention(s)

Skin conditionsSkin Condition

Skin conditions: Participants with skin conditions such as AK or participants without any skin conditions (healthy skin)

Skin Condition: Participants with Skin conditions or participants without any skin conditions (Healthy)

Study summary

The overall objective of this study is to use VIO/FG-30350 ("VIO") to observe microscopic skin structure in people of different skin health at different anatomic locations and correlate microscopic features with macroscopic features.

Eligibility

Sex
ALL
Min age
2 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: Participants, ages 2 - 90 years old Participant, or guardian, if applicable, must be willing to provide written informed consent prior to enrollment and agree to comply with protocol requirements. If applicable, child must be willing to provide written assent prior to enrollment and agree to comply with protocol requirements. Participant or guardian, if applicable, must have sufficient mental capacity to understand the Informed Consent and provide clinically relevant and reliable feedback regarding their experience with the device. Participant and guardian, if applicable, must comply with the protocol requirements. Participant or guardian, if applicable, must agree that anonymized personal data will be made available to Study Sponsor and requisite regional and international regulatory bodies Exclusion Criteria: Any general health condition or systemic disease that may represent, in the opinion of the Principal Investigator, a potential increased risk associated with device use Currently infected with a communicable skin infection (e.g., shingles or methicillin-resistant S. aureus), which does not include local and minimally pathogenic or non-pathogenic infections distant from the imaging location(s) (e.g., warts, acne) Any known allergies to any materials used in the preparation of skin and/or device use Has a temporary or permanent electrical implanted medical device \-

Primary outcome measure(s)

  • Correlational relationship — 7 days
    Correlational relationship of: melanin content quantified from noninvasive VIO images with macroscopic skin tone as measured with a colorimeter.
  • Correlational relationship — 7 days
    Correlational relationship of: 1. melanin content quantified from noninvasive VIO images with 2. macroscopic skin tone as measured with a colorimeter.

Trial sites (1)

FacilityCityRegionStatus
Enspectra Health Mountain View California Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07188948 on ClinicalTrials.gov ↗ ← All trials in the USA